search
Back to results

Diagnostic Yield of Agitated Exudative Non-infected Pleural Effusion

Primary Purpose

Pleural Effusion

Status
Active
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Agitated Pleural Fluid Thoracentesis
Sponsored by
Alexandria University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Pleural Effusion focused on measuring pleural effusion, exudate

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age > 18 years old At least a moderate amount of pleural fluid collection (2 or more intercostal spaces on thoracic ultrasound) Exclusion Criteria: Minimal - mild pleural fluid deemed unsuitable for aspiration and agitation Hemodynamic instability Pleural infection based on clinical presentation, imaging or laboratory investigations and pleural fluid examination showing glucose < 40 mg/dL or pH <7.2 with lower respiratory infection, positive gram stain or bacterial culture or pus on aspiration

Sites / Locations

  • Chest Diseases Department, Alexandria University Faculty of Medicine

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Standard thoracentesis followed by pre-aspiration fluid agitation

Arm Description

Participants will undergo the standard thoracentesis followed by the experimental pre-aspiration fluid agitation technique

Outcomes

Primary Outcome Measures

Diagnostic yield of the cytological analysis
Percentage of samples with a positive cytological result among both aspiration techniques
Diagnostic yield of the microbiolocal analysis (mycobacterial / fungal)
Percentage of samples with a evidence of mycobacterial / fungal elements among both aspiration techniques
Incidence of adverse events with pre-aspiration fluid agitation
Percentage of patients with incidence of adverse events during or right after pre-aspiration fluid agitation including pneumothorax or significant pain or cough or oxygen desaturation

Secondary Outcome Measures

Protein level difference between both aspiration method
Difference in Protein levels in the aspirated fluid via both techniques
Lactate dehydrogenase (LDH) level difference between both aspiration method
Difference in LDH levels in the aspirated fluid via both techniques
Glusose level difference between both aspiration method
Difference in glucose levels in the aspirated fluid via both techniques
Neutrophilic count difference between both aspiration method
Difference in neutrophilic count in the aspirated fluid via both techniques
Lymphocytic count difference between both aspiration method
Difference in lymphocytic count in the aspirated fluid via both techniques

Full Information

First Posted
April 6, 2023
Last Updated
April 19, 2023
Sponsor
Alexandria University
search

1. Study Identification

Unique Protocol Identification Number
NCT05819294
Brief Title
Diagnostic Yield of Agitated Exudative Non-infected Pleural Effusion
Official Title
A Feasibility Study of the Diagnostic Yield of Pre-aspiration Pleural Fluid Agitation in Non-infected Pleural Effusion
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 1, 2023 (Actual)
Primary Completion Date
March 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Alexandria University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this study is to compare the diagnostic yield in terms of cellular content and biochemical characteristics of pre-aspiration agitated pleural fluid versus that of conventionally aspirated fluid in pleural infection patients. The hypothesis is that the agitated fluid would be more representative and thus may aid the diagnosis of non-infected exudative pleural effusions.
Detailed Description
Transudation or exudation are the two mechanisms by which fluid accumulates, where Starling forces' imbalance is responsible for the former and inflammatory increase in capillary permeability accounts for the latter. Despite the history and presentation commonly suggesting the underlying etiology, pleural fluid aspiration and analysis is frequently required for confirmation of the nature and cause of the effusion. Aspirated pleural fluid is routinely subjected to biochemical analysis as well as microbiological and cytological analysis especially when infection or neoplasia is suspected. One drawback however to thoracentesis analysis is the relatively low diagnostic yield in different forms of exudative effusion. Tuberculous pleural effusions have a yield of <10% on acid-fast bacilli smears and overall yield <30% on solid culture. Conventional cytologic analysis from malignant pleural effusions also show a relatively low overall yield of around 51%, though this could be highly variable depending on the primary cancer involved (6% in mesothelioma - 80% in ovarian adenocarcinoma).In addition, it is not uncommon for analysis results to widely vary in the same patient in those with loculated and in malignant pleural effusions. This could be attributed to the compartmentalization in complex septated collections and heterogenous distribution of cellular components throughout the pleural space. The gold standard however in diagnosing unexplained exudative pleural effusions is pleural biopsy which is technically demanding and sometimes associated with longer hospital stay along with the increased incurred costs. The investigators propose a method for improving the representativeness of pleural fluid samples via pleural agitation prior to aspiration in exudative noninfected pleural effusion. The aim is to test the feasibility and safety of using pleural fluid agitation prior to aspiration and to investigate the potential for an improved diagnostic yield using this novel thoracentesis technique in patients with exudative non-infected pleural effusion. A control group of 10 participants with transudative pleural effusion (based on history, clinical picture, and imaging) will be included to exclude any effect of the agitation procedure on the biochemical profile of the pleural fluid. These will include patients with uncontrolled heart failure, renal or hepatic impairment presenting with classical uncomplicated free pleural effusion.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pleural Effusion
Keywords
pleural effusion, exudate

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All participants will undergo both thoracentesis techniques; the standard and the experimental pre-aspiration agitated fluid techniques
Masking
None (Open Label)
Masking Description
Laboratory personnel responsible for the cytological and biochemical analysis will be blinded to the identity of the paired samples
Allocation
N/A
Enrollment
55 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard thoracentesis followed by pre-aspiration fluid agitation
Arm Type
Experimental
Arm Description
Participants will undergo the standard thoracentesis followed by the experimental pre-aspiration fluid agitation technique
Intervention Type
Procedure
Intervention Name(s)
Agitated Pleural Fluid Thoracentesis
Intervention Description
Using a 16-18 gauge cannula, a standard thoracentesis will be performed then a sample of pleural fluid will be aspirated and rapidly flushed into the pleural space and redrawn again for a few cycles before a sample is finally drawn into the collection syringe
Primary Outcome Measure Information:
Title
Diagnostic yield of the cytological analysis
Description
Percentage of samples with a positive cytological result among both aspiration techniques
Time Frame
14 days
Title
Diagnostic yield of the microbiolocal analysis (mycobacterial / fungal)
Description
Percentage of samples with a evidence of mycobacterial / fungal elements among both aspiration techniques
Time Frame
14 days
Title
Incidence of adverse events with pre-aspiration fluid agitation
Description
Percentage of patients with incidence of adverse events during or right after pre-aspiration fluid agitation including pneumothorax or significant pain or cough or oxygen desaturation
Time Frame
14 days
Secondary Outcome Measure Information:
Title
Protein level difference between both aspiration method
Description
Difference in Protein levels in the aspirated fluid via both techniques
Time Frame
results within 1 day of sampling
Title
Lactate dehydrogenase (LDH) level difference between both aspiration method
Description
Difference in LDH levels in the aspirated fluid via both techniques
Time Frame
results within 1 day of sampling
Title
Glusose level difference between both aspiration method
Description
Difference in glucose levels in the aspirated fluid via both techniques
Time Frame
results within 1 day of sampling
Title
Neutrophilic count difference between both aspiration method
Description
Difference in neutrophilic count in the aspirated fluid via both techniques
Time Frame
results within 1 day of sampling
Title
Lymphocytic count difference between both aspiration method
Description
Difference in lymphocytic count in the aspirated fluid via both techniques
Time Frame
results within 1 day of sampling

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 18 years old At least a moderate amount of pleural fluid collection (2 or more intercostal spaces on thoracic ultrasound) Exclusion Criteria: Minimal - mild pleural fluid deemed unsuitable for aspiration and agitation Hemodynamic instability Pleural infection based on clinical presentation, imaging or laboratory investigations and pleural fluid examination showing glucose < 40 mg/dL or pH <7.2 with lower respiratory infection, positive gram stain or bacterial culture or pus on aspiration
Facility Information:
Facility Name
Chest Diseases Department, Alexandria University Faculty of Medicine
City
Alexandria
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Diagnostic Yield of Agitated Exudative Non-infected Pleural Effusion

We'll reach out to this number within 24 hrs